BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: Using guidelines to make rational treatment choices

Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: Using guidelines to make rational treatment choices'. Together they form a unique fingerprint.

Medicine & Life Sciences